Hegenbart U - Search Results

1

Autologous/reduced-intensity allogeneic stem cell transplantation vs autologous transplantation in multiple myeloma: long-term results of the EBMT-NMAM2000 study.

Gahrton G, Iacobelli S, Björkstrand B, Hegenbart U, Gruber A, Greinix H, Volin L, Narni F, Carella AM, Beksac M, Bosi A, Milone G, Corradini P, Schönland S, Friberg K, van Biezen A, Goldschmidt H, de Witte T, Morris C, Niederwieser D, Garderet L, Kröger N; EBMT Chronic Malignancies Working Party Plasma Cell Disorders Subcommittee. Gahrton G, et al. Among authors: hegenbart u. Blood. 2013 Jun 20;121(25):5055-63. doi: 10.1182/blood-2012-11-469452. Epub 2013 Mar 12. Blood. 2013. PMID: 23482933 Free article. Clinical Trial.

2

[Gastrointestinal amyloidosis in IgG-kappa-light-chain plasmocytoma].

Hegenbart U, Goldschmidt H. Hegenbart U, et al. Dtsch Med Wochenschr. 1995 Aug 25;120(34-35):1187. Dtsch Med Wochenschr. 1995. PMID: 7656858 German. No abstract available.

3

[Paroxysmal nocturnal hemoglobinuria. Differentiation from other acquired hemolytic anemias and confirming the diagnosis].

Hegenbart U, Goldschmidt H. Hegenbart U, et al. Z Arztl Fortbild (Jena). 1994 Jan;88(1):59-62. Z Arztl Fortbild (Jena). 1994. PMID: 8154143 German. No abstract available.

4

Mobilization of peripheral blood progenitor cells with high-dose cyclophosphamide (4 or 7 g/m2) and granulocyte colony-stimulating factor in patients with multiple myeloma.

Goldschmidt H, Hegenbart U, Haas R, Hunstein W. Goldschmidt H, et al. Among authors: hegenbart u. Bone Marrow Transplant. 1996 May;17(5):691-7. Bone Marrow Transplant. 1996. PMID: 8733683 Clinical Trial.

5

Sequential high-dose treatment with peripheral blood progenitor cell transplantation in patients with multiple myeloma.

Goldschmidt H, Hegenbart U, Moos M, Eugenhart R, Wannenmacher M, Haas R, Hunstein W. Goldschmidt H, et al. Among authors: hegenbart u. Stem Cells. 1995 Dec;13 Suppl 3:36-41. doi: 10.1002/stem.5530130707. Stem Cells. 1995. PMID: 8747987 Clinical Trial.

6

High-dose therapy with peripheral blood progenitor cell transplantation in multiple myeloma.

Goldschmidt H, Hegenbart U, Wallmeier M, Hohaus S, Engenhart R, Wannenmacher M, Haas R. Goldschmidt H, et al. Among authors: hegenbart u. Ann Oncol. 1997 Mar;8(3):243-6. doi: 10.1023/a:1008252227512. Ann Oncol. 1997. PMID: 9137792 Free article. Clinical Trial.

7

[Malignant lymphoma. Pathology, diagnosis, therapy].

Goldschmidt H, Wallmeier M, Hegenbart U, Haas R. Goldschmidt H, et al. Among authors: hegenbart u. Radiologe. 1997 Jan;37(1):1-9. doi: 10.1007/s001170050171. Radiologe. 1997. PMID: 9157471 Review. German.

8

Peripheral blood progenitor cell transplantation in multiple myeloma following high-dose melphalan-based therapy.

Goldschmidt H, Hegenbart U, Wallmeier M, Hohaus S, Engenhart R, Wannenmacher M, Haas R. Goldschmidt H, et al. Among authors: hegenbart u. Recent Results Cancer Res. 1998;144:27-35. doi: 10.1007/978-3-642-46836-0_4. Recent Results Cancer Res. 1998. PMID: 9304704

9

Factors influencing collection of peripheral blood progenitor cells following high-dose cyclophosphamide and granulocyte colony-stimulating factor in patients with multiple myeloma.

Goldschmidt H, Hegenbart U, Wallmeier M, Hohaus S, Haas R. Goldschmidt H, et al. Among authors: hegenbart u. Br J Haematol. 1997 Sep;98(3):736-44. doi: 10.1046/j.1365-2141.1997.2783095.x. Br J Haematol. 1997. PMID: 9332333 Free article.

10

High-dose chemotherapy in multiple myeloma.

Goldschmidt H, Hegenbart U, Wallmeier M, Moos M, Haas R. Goldschmidt H, et al. Among authors: hegenbart u. Leukemia. 1997 Dec;11 Suppl 5:S27-31. Leukemia. 1997. PMID: 9436935 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

272 results

Search Page

Filters